What promise does PCSK9 hold?

被引：4

作者：

Kastelein, JJP ^{[1
]}

Fouchier, SW ^{[1
]}

Defesche, JC ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 10期

关键词：

D O I：

10.1016/j.jacc.2005.02.056

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1620 / 1621

页数：2

共 17 条

[1] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[2] NARC-1/PCSK9 and its natural mutants -: Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol [J].

Benjannet, S ;

Rhainds, D ;

Essalmani, R ;

Mayne, J ;

Wickham, L ;

Jin, WJ ;

Asselin, MC ;

Hamelin, J ;

Varret, M ;

Allard, D ;

Trillard, M ;

Abifadel, M ;

Tebon, A ;

Attie, AD ;

Rader, DJ ;

Boileau, C ;

Brissette, L ;

Chrétien, M ;

Prat, A ;

Seidah, NG .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48865-48875

[3] USE OF MUTANT FIBROBLASTS IN ANALYSIS OF REGULATION OF CHOLESTEROL-METABOLISM IN HUMAN CELLS [J].

BROWN, MS ;

BRANNAN, PG ;

BOHMFALK, HA ;

BRUNSCHEDE, GY ;

DANA, SE ;

HELGESON, J ;

GOLDSTEIN, JL .

JOURNAL OF CELLULAR PHYSIOLOGY, 1975, 85 (02) :425-436

[4] A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis [J].

Chen, SN ;

Ballantyne, CM ;

Gotto, AM ;

Tan, YL ;

Willerson, JT ;

Marian, AJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1611-1619

[5] No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes [J].

Damgaard, D ;

Jensen, JM ;

Larsen, ML ;

Soerensen, VR ;

Jensen, HK ;

Gregersen, N ;

Jensen, LG ;

Faergeman, O .

ATHEROSCLEROSIS, 2004, 177 (02) :415-422

[6] Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia [J].

Dubuc, G ;

Chamberland, A ;

Wassef, H ;

Davignon, J ;

Seidah, NG ;

Bernier, L ;

Prat, A .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) :1454-1459

[7] COMPETITIVE INHIBITION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE BY ML-236A AND ML-236B FUNGAL METABOLITES, HAVING HYPOCHOLESTEROLEMIC ACTIVITY [J].

ENDO, A ;

KURODA, M ;

TANZAWA, K .

FEBS LETTERS, 1976, 72 (02) :323-326

[8] FAMILIAL HYPERCHOLESTEROLEMIA - IDENTIFICATION OF A DEFECT IN REGULATION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE-ACTIVITY ASSOCIATED WITH OVERPRODUCTION OF CHOLESTEROL [J].

GOLDSTEIN, JL ;

BROWN, MS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (10) :2804-2808

[9]

INNERARITY TL, 1990, J LIPID RES, V31, P1337

[10] FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100 - LOW-DENSITY LIPOPROTEINS WITH ABNORMAL RECEPTOR-BINDING [J].

INNERARITY, TL ;

WEISGRABER, KH ;

ARNOLD, KS ;

MAHLEY, RW ;

KRAUSS, RM ;

VEGA, GL ;

GRUNDY, SM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) :6919-6923

← 1 2 →